SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007632
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:01
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20240331x10q.htm   iXBRL 10-Q 992582
2 EX-31.1 glyc-20240331xex31d1.htm EX-31.1 16950
3 EX-31.2 glyc-20240331xex31d2.htm EX-31.2 16766
4 EX-32.1 glyc-20240331xex32d1.htm EX-32.1 9429
  Complete submission text file 0001558370-24-007632.txt   4855538

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20240331.xsd EX-101.SCH 37318
6 EX-101.CAL glyc-20240331_cal.xml EX-101.CAL 33380
7 EX-101.DEF glyc-20240331_def.xml EX-101.DEF 177969
8 EX-101.LAB glyc-20240331_lab.xml EX-101.LAB 359441
9 EX-101.PRE glyc-20240331_pre.xml EX-101.PRE 305295
69 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240331x10q_htm.xml XML 662301
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 24931251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)